A Biological Investigational New Drug (BIND) application is an FDA submission that authorizes human testing of a biologic product in the United States.
BIND applications include preclinical safety data, manufacturing information, and proposed study protocols. FDA review ensures appropriate safety controls before enrollment begins. Approval enables early-phase biologic clinical trials under regulatory oversight.